Last reviewed · How we verify

NCT05102227: CROSS LEFT

Cardiac ResynchronizatiOn and arrhythmiaS Sensing Via the LEFT Bundle.

Status unknown Last updated 1 November 2021
What this trial tests

trial testing Left bundle branch area pacing in Left Bundle Branch Area Pacing in 10 participants. Status unknown.

Timeline
25 March 2021
Primary endpoint
31 July 2021
31 December 2022

Quick facts

Lead sponsorUniversity Hospital, Tours
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10
Start date25 March 2021
Primary completion31 July 2021
Estimated completion31 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

18 and older, any sex, with Left Bundle Branch Area Pacing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of ventricular arrhythmias sensing via a left bundle branch area pacing lead.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dual-chamber ICD for left bundle branch area pacing: the cardiac resynchronization and arrhythmia sensing via the left bundle (cross-left) pilot study.
    Clementy N, Bodin A, Ah-Fat V, Babuty D, et al · · 2023 · cited 20× · PMID 35970951 · DOI 10.1007/s10840-022-01342-6

Verify or expand the search:

Other trials of Left bundle branch area pacing

Trials testing the same drug.

Other recruiting trials for Left Bundle Branch Area Pacing

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05102227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing